Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhengchaihuyin Granule is a Traditional Chinese Medicine (TCM) product primarily used for the treatment of the common cold, specifically the "wind-cold" type. It is a multi-herb formulation based on a classic TCM prescription. The preparation typically includes extracts from *Bupleurum chinense* (Chaihu), *Saposhnikovia divaricata* (Fangfeng), *Paeonia lactiflora* (Baishao), *Citrus reticulata* (Chenpi), *Zingiber officinale* (Shengjiang), and *Glycyrrhiza uralensis* (Gancao). It is indicated for the relief of symptoms such as fever, chills, headache, nasal congestion, and body aches. The drug is manufactured by Nantong Jidesheng and is widely available in the Chinese market as an over-the-counter remedy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zhengchaihuyin granule.